Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Osteoporosis 1Neoplasms 1Musculoskeletal Diseases 1Hyperparathyroidism 1Humoral Hypercalcemia Of Malignancy 1Endocrine System Diseases 1

Interventions

Zoledronic Acid 14Vitamin D 8Risedronic Acid 8Letrozole 7Calcium 7Calcium Carbonate 5Absorptiometry, Photon 5Cholecalciferol 4Denosumab 3Alendronate 3bicalutamide 2Resistance Training 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Calcium Gluconate 2Calcium Citrate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1parathyroid hormone-related peptide (1-36) 1X-Rays 1Toremifene 1Technetium 1Raloxifene Hydrochloride 1Radiotherapy 1Progestins 1Lysine Acetyltransferase 5 1Linseed Oil 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Osteoporosis × parathyroid hormone-related peptide (1-36) × Clear all
NCT00580788 2016-02-11

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

University of Pittsburgh

Phase EARLY_PHASE1 Completed
14 enrolled 16 charts
Head & Neck

Humoral Hypercalcemia Of Malignancy, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡